International Journal of Oral Biology

The Korean Academy of Oral Biology (대한구강생물학회)
권호 표지
DOI QR코드

DOI QR Code

Screening of Antibiotics that Selectively Inhibit a Bacterial Species Associated with a Recurrent Aphthous Stomatitis Risk

  • Lee, Ahreum (Department of Immunology and Molecular Microbiology, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Kim, Yunji (Department of Immunology and Molecular Microbiology, School of Dentistry and Dental Research Institute, Seoul National University) ;
  • Choi, Youngnim (Department of Immunology and Molecular Microbiology, School of Dentistry and Dental Research Institute, Seoul National University)
  • Received : 2017.07.20
  • Accepted : 2017.08.11
  • Published : 2017.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Recurrent aphthous stomatitis (RAS) is a common oral mucosal disorder for which no curative treatment is available. We previously reported that decreased Streptococcus salivarius and increased Acinetobacter johnsonii on the oral mucosa are associated with RAS risk. The purpose of this study was to identify antibiotics that selectively inhibit A. johnsonii but minimally inhibit oral mucosal commensals. S. salivarius KCTC 5512, S. salivarius KCTC 3960, A. johnsonii KCTC 12405, Rothia mucilaginosa KCTC 19862, and Veillonella dispar KCOM 1864 were subjected to antibiotic susceptibility test using amoxicillin, cefotaxime, gentamicin, clindamycin, and metronidazole in liquid culture. The minimal inhibitory concentration (MIC) was defined as the concentration that inhibits 90% of growth. Only gentamicin presented a higher MIC for A. johnsonii than MICs for S. salivarius and several oral mucosal commensals. Interestingly, the growth of S. salivarius increased 10~200% in the presence of sub-MIC concentrations of gentamicin, which was independent of development of resistance to gentamicin. In conclusion, gentamicin may be useful to restore RAS-associated imbalance in oral microbiota by selectively inhibiting the growth of A. johnsonii but enhancing the growth of S. salivarius.

Keywords

References

  1. Scully C. Aphthous Ulceration. N Engl J Med. 2006;355:165-172. http://dx.doi.org/10.1056/NEJMcp054630.
  2. Scully C, Porter SR. Oral mucosal disease: Recurrent aphthous stomatitis. Br J Oral Maxillofac Surg. 2008;46:198-206. http://dx.doi.org/10.1016/j.bjoms.2007.07.201
  3. Mustafa JA. Prevalence of recurrent aphthous ulceration experience in patients attending Piramird dental speciality in Sulaimani City. J Clin Exp Dent. 2013;5:e89-e94. http://dx.doi.org/10.4317/jced.51042
  4. Patil S, Reddy SN, Maheshwari S, Khandelwal S, Shruthi D, Doni B. Prevalence of recurrent aphthous ulceration in the Indian Population. J Clin Exp Dent. 2014;6:e36-e40. http://dx.doi.org/10.4317/jced.51227
  5. Jurge S, Kuffer R, Scully C, Porter SR. Recurrent aphthous stomatitis. Oral Dis. 2006;12:1-21. http://dx.doi.org/10.1111/j.1601-0825.2005.01143.x
  6. Slebioda Z, Szponar E, Kowalska A. Etiopathogenesis of Recurrent Aphthous Stomatitis and the Role of Immunologic Aspects: Literature Review. Arch Immunol Ther Exp (Warsz). 2014;62:205-215. http://dx.doi.org/10.1007/s00005-013-0261-y
  7. Irene BG, Yolanda JS, Ariadna CL. Treatment of recurrent aphthous stomatitis. J Clin Exp Dent. 2014;6:e168-e174. http://dx.doi.org/10.4317/jced.51401
  8. Preeti L, Magesh KT, Rajkumar K, Raghavendhar K. Recurrent aphthous stomatitis. J Oral Maxillofac Pathol. 2011;15:252-256. http://dx.doi.org/10.4103/0973-029X.86669
  9. Kim YJ, Choi YS, Baek KJ, Yoon SH, Park HK, Choi Y. Mucosal and salivary microbiota associated with recurrent aphthous stomatitis. BMC Microbiol. 2016;16:57. http://dx.doi.org/10.1186/s12866-016-0673-z
  10. Epstein JB, Chong S, Le ND. A survey of antibiotic use in dentistry. J Am Dent Assoc. 2000;131:1600-1609. http://dx.doi.org/10.14219/jada.archive.2000.0090
  11. Verhaaren H, Claeys G, Verschraegen G, De Niel C, Leroy J, Clement D. Endocarditis from a dental focus. Importance of oral hygiene in valvar heart disease. Int J Cardiol. 1989;23:343-347. http://dx.doi.org/10.1016/0167-5273(89)90194-0
  12. Bohnen JMA, Solomkin JS, Dellinger EP, Bjornson HS, Page CP. Guidelines for Clinical Care: Anti-infective Agents for Intra-abdominal Infection. Arch Surg. 1992;127:83-89. http://dx.doi.org/10.1001/archsurg.1992.01420010097015
  13. Silici S, Kutluca S. Chemical composition and antibacterial activity of propolis collected by three different races of honeybees in the same region. J Ethnopharmacol. 2005;99:69-73. http://dx.doi.org/10.1016/j.jep.2005.01.046
  14. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48 Suppl 1:5-16. https://doi.org/10.1093/jac/48.suppl_1.5
  15. Hoffman LR, D'Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature. 2005;436:1171-1175. http://dx.doi.org/10.1038/nature03912
  16. Jones C, Allsopp L, Horlick J, Kulasekara H, Filloux A. Subinhibitory Concentration of Kanamycin Induces the Pseudomonas aeruginosa type VI Secretion System. PLoS One. 2013;8:e81132. http://dx.doi.org/10.1371/journal.pone.0081132
  17. Tsai SH, Lai HC, Hu S. Subinhibitory Doses of Aminoglycoside Antibiotics Induce Changes in the Phenotype of Mycobacterium abscessus. Antimicrob Agents Chemother. 2015;59:6161-6169. http://dx.doi.org/10.1128/AAC.01132-15.
  18. Linares JF, Gustafsson I, Baquero F, Martinez JL. Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci U S A. 2006;103:19484-19489. http://dx.doi.org/10.1073/pnas.0608949103
  19. Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014;16:1024-1033. http://dx.doi.org/10.1111/cmi.12308
  20. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis RE, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-1031. http://dx.doi.org/10.1038/nature05414
  21. Turnbaugh JP, Hamady M, Yatsunenko T, Cantarel LB, Duncan A, Ley RE, Sogin LM, Jones JW, Roe AB, Affourtit PJ, Egholm M, Henrissat B, Heath CA, Knight R, Gordon JI. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-484. http://dx.doi.org/10.1038/nature07540
  22. Castellarin M, Warren LR, Freeman DJ, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299-306. http://dx.doi.org/10.1101/gr.126516.111
  23. Hajishengallis G, Lambris DJ. Complement and dysbiosis in periodontal disease. Immunobiology. 2012;217:1111-1116. http://dx.doi.org/10.1016/j.imbio.2012.07.007
  24. Whitmore SE, Lamont RJ. Oral Bacteria and Cancer. PLoS Pathog. 2014;10:e1003933. http://dx.doi.org/10.1371/journal.ppat.1003933
  25. Lamont RJ, Hajishengallis G. Polymicrobial synergy and dysbiosis in inflammatory disease. Trends Mol Med. 2015;21:172-183. http://dx.doi.org/10.1016/j.molmed.2014.11.004